Showing results (151-160 of 229) with videos related to

Sort By:
Pageof 23
Gynecologic Oncology|September 23, 2017
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancerG Rustin, I Vergote, J P Micha, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 29, 2005
Ultrasound features of different histopathological subtypes of borderline ovarian tumorsE Fruscella, A C Testa, G Ferrandina, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 31, 2020
Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic diseaseA Vandewal, K Delbecque, A S Van Rompuy, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2019
Combining conventional therapy with immunotherapy: A risky business?A Coosemans, A Vankerckhoven, T Baert, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2012
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancerS B Kaye, C J Poole, A Dańska-Bidzińska, et al.
Gynecologic Oncology|November 27, 2012
Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD studyE I Braicu, C Fotopoulou, T Van Gorp, et al.
Breast Cancer Research and Treatment|November 22, 2017
Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional studyO Brouckaert, K Van Asten, A Laenen, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 4, 2010
Improving the preoperative classification of adnexal masses as benign or malignant by second-stage testsA Daemen, L Valentin, R Fruscio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatinG B Kristensen, I Vergote, G Stuart, et al.
Pageof 23